Priyanka Hinton brings a wealth of experience in the pharmaceutical industry and the NHS to her new role as Customer Solutions Director at CHASE.
"I'm thrilled to be joining CHASE at such a pivotal time," Priyanka said. "I'm confident that my experience in leading high-performing teams and driving customer success will be a valuable asset to the company."
In her previous role at Pfizer, Priyanka was responsible for commercialising the Covid-19 treatment and leading its sales performance. She also served as a Senior Immunisation Manager at NHS England, responsible for leading a team of commissioners to successfully deliver the Childhood and Adult Immunisation Programmes.
"Priyanka's extensive experience in commercial clinical services and optimisation will be a valuable asset to our team and our customers," said Graham Hawthorn, Chief Executive Officer at CHASE. "We are confident that Priyanka will make a significant contribution to our continued success."
Please join us in welcoming Priyanka to the CHASE team!
This post was originally published in 2024.
Explore our latest thinking, event updates and industry insights to stay informed.
Kent and Medway has signed the first local variation of the PCN DES, worth £10 million a year. CHASE assesses what the framework still leaves unsettled.
From April 2027, NHS Carbon Reduction Plan rules demand full scope 3 emissions data. CHASE assesses what this means for pharma and medtech suppliers.
Yvette Cooper is the UK's new health secretary after a reshuffle that also reshaped the medtech brief. Here's what it means for pharma, medtech and NHS teams.
.svg)
